Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Fosaprepitant Dimeglumine for Injection

Approval Number

国药准字H20234005

Company杭州九源基因工程股份有限公司

Registration Date

August 1, 2023

Drug Information

Generic Name

注射用福沙匹坦双葡甲胺

Dosage Form

注射剂

Strength

0.15g（按C₂₃H₂₂F₇N₄O₆P计）

Drug Type

化学药品

Registration Date

August 1, 2023

Company Information

Applicant Company

Company Name杭州九源基因工程股份有限公司

Company Address

浙江省杭州市钱塘区白杨街道8号大街23号

Manufacturing Company

Company Name杭州九源基因工程股份有限公司

Company Address

杭州经济技术开发区八号大街东

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

注射用福沙匹坦双葡甲胺 - NMPA 批准文号 | MedPath